Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
Differentiation of neuromyelitis optica from multiple sclerosis in a cohort from the mainland of China.
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
The role of IL-17 in CNS diseases.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Smoking as a risk factor for multiple sclerosis.
Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.
Genetic proof for the transient nature of the Th17 phenotype.
Distribution of axon diameters in cortical white matter: an electron-microscopic study on three human brains and a macaque.
Oligodendroglia metabolically support axons and maintain structural integrity.
Autoantigens and autoantibodies in multiple sclerosis.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Discovery of novel disease-specific and membrane-associated markers in a mouse model of multiple sclerosis.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.

Pages